Dec
18
2025
Neurocrine Biosciences advances schizophrenia treatment with new Phase 2a clinical study
Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has announced the initiation of a Phase …
